Edit |   |
---|---|
Antigenic Specificity | Ganglioside GD4, Human (Mitumomab biosimilar) |
Clone | Mitumomab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG2b kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF, Neut, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human Ganglioside GD4 Recombinant Antibody (Mitumomab). Mitumomab (BEC-2) is a mouse anti-BEC-2 monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination. Mitumomab attacks tumour cells, while the vaccine is thought to activate the immune system. It was developed by ImClone and Merck. |
Immunogen | n/a |
Other Names | Anti-Ganglioside GD4 Recombinant Antibody, Research Grade Mitumomab, Anti-Human Ganglioside GD4 Recombinant Antibody(Mitumomab), BEC2, Antibody Drug Analogues, Monoclonal Antibody, YR1070, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 216503-58-1 |
Catalog # | YR1070 |
Price | please inquire |
Order / More Info | Ganglioside GD4, Human (Mitumomab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |